Coverage of "Clinical Trial" on Cryptosearcher: the stories and the context behind them.
Moderna's stock rose 4% after Health Canada authorized the first human trial of its Bundibugyo Ebola vaccine candidate. The study will test safety and immune response in roughly 80 healthy volunteers across Canada.
August 5, 2026